Ertapenem contraindications: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Ertapenem}} {{CMG}} *INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in ...") |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Ertapenem}} | {{Ertapenem}} | ||
{{CMG}} | {{CMG}} | ||
==Contraindications== | |||
*INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. | *INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. | ||
Revision as of 14:40, 24 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Contraindications
- INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams.
- Due to the use of lidocaine HCl as a diluent, INVANZ administered intramuscularly is contraindicated in patients with a known hypersensitivity to local anesthetics of the amide type.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021337s018lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.